Download presentation
Presentation is loading. Please wait.
Published byAnne-Mari Aaltonen Modified over 6 years ago
1
577 marketing authorisations granted (356 active ingredients) by EU centralized procedure, 1995-2009
522 marketing authorisations granted (339 active ingredients) selected for the analysis 55 marketing authorisations withdrawn, suspended and/or not renewed (45 active ingredients) excluded from the analysis 2 marketing authorisations granted to medicinal products with no specific indication (1 active ingredient) excluded 520 marketing authorisations granted (338 active ingredients) finally included in the analysis with disease burden measures
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.